Frequent hand washing and use of PPE during COVID-19 pandemic – what about skin care?
The potential issue with skin irritation and discomfort may soon play a deleterious effect on adherence to health officials guidelines by the general population.

As the new coronavirus that causes COVID-19 continues to spread globally, health officials have emphasized that washing one’s hands frequently and properly is one of the most effective ways of removing the virus from the skin surface to prevent the spread of infection and disinfecting them with an alcohol-based product is the best alternative when soap and water are not available.

Guidance from the Centers for Disease Control and Prevention (CDC) indicates people should scrub their hands for at least 20 seconds to effectively curb the spread of the virus. Alcohol-based hand sanitizers that contain at least 60% alcohol can also be used to rid hands of germs, though they are not as effective as soap and water at removing visible dirt.

Frequent hand washing, though a reliable way to ward off illness, can lead to and exacerbate dry skin issues. In the same way, the constant use of alcohol-based hand sanitizers strips the skin of its natural and protective oils and can potentially dry and crack the skin surface. The alcohol content may also cause a sensation of burning, especially on compromised skin.

Nails are affected as well with frequent hand washing and/or application of hand sanitizer and can become cracked or brittle. Contact dermatitis, both irritant and allergic, can occur with increased use of disinfectants.

At the same time, the constant use of Personal Protective Equipment (PPE) by healthcare professionals, as well as the requirement by local governments to wear masks when social distancing cannot be maintained in public places, pose a potential risk of skin irritation from use of such products.

The potential issue with skin irritation and discomfort may soon play a deleterious effect on adherence to health officials guidelines by the general population.

How to keep your hands clean and in good conditions?

Once you’ve washed your hands for at least 20 seconds, it is important to patting rather than rubbing them, which can irritate the skin. Once your hands are dry, use a hand cream to seal in the moisture. Ideal hand creams should not include irritants, known allergens or fragrances. Among the many kinds of moisturizers, hand creams are better than body lotion because they are generally more nourishing. Lotions, which are primarily water-based, can further dry out skin because the water evaporates more quickly. Creams, which are often oil-based, are more effective in moisturizing the skin after washing hands.

References:

  1. World Health Organization. Coronavirus disease (COVID-19) advice for the public. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public
  2. Center for Disease Control and Prevention. Coronavirus Disease 2019 (COVID-19) Protect Yourself. https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/prevention.html
  3. Lan, J., Song, Z., Miao, X., Li, H., Li, Y., Dong, L., Yang, J., An, X., Zhang, Y., Yang, L., Zhou, N., Yang, L., Li, J., Cao, J., Wang, J., & Tao, J.. Skin damage among health care workers managing coronavirus disease. Journal of the American Academy of Dermatology, 2020, 82(5), 1215–1216. https://doi.org/10.1016/j.jaad.2020.03.014
  4. Darlenski, R, Tsankov, N. Covid-19 pandemic and the skin -What should dermatologists know? Clinics in Dermatology, 2020. https://doi.org/10.1016/j.clindermatol.2020.03.012
  5. Slotosch, M., Kampf, G., Loffler, H. Effects of Disinfectants and Detergents on Skin Irritation. Contact Dermatitis, 2007, 57(4):235-41 https://pubmed.ncbi.nlm.nih.gov/17868216/

further
reading

medical devices

Safety Reporting in Clinical Investigations: a Gap Analysis of Guidance Documents 

Safety reporting in clinical investigations of medical devices shall be performed in line with Article 80(2) of the EU MDR. On May 2020, it was published the MDCG 2020-10/1, outlining the procedures for safety reporting in clinical investigations of medical devices under the EU MDR. However, on October 2022 the Medical Device Coordination Group (MDCG) published an updated version of the MDCG 2020-10/1, the MDCG 2020-10/1 Rev 1. This article highlights the updates included in the new revision, analysing the gaps between both documents.

Read More »
medical devices

Roles and Responsibilities of an Authorised Representative under EU MDR and IVDR 

If a medical device manufacturer is not established in a Member State, the devices can only be placed on the Union market if the manufacturer designates an authorised representative. The authorised representative plays a pivotal role in ensuring the compliance of the devices with EU regulation, serving as point of contact. The obligations and responsibilities of authorised representative are outlined on Article 11 of both MDR and IVDR, but clarification of relevant requirements is described in MDCG 2022-16 of October 2022.

Read More »
medical devices

Understanding the ISO Standards Lifecycle

ISO Standards cover a huge range of activities, representing the distilled wisdom of people with expertise in their subject matter and providing the regulators with a sound basis to develop better legislation. ISO Standards are diverse, addressing from the shoe size we wear to the quality of air we breathe. The medical device sector is no exception. ISO has many International Standards and guidance documents aimed at helping the sector ensure safe and effective medical devices while meeting the multitude of national, regional and international regulatory requirements. But how exactly is a Standard developed, reviewed and withdraw?

Read More »
medical devices

Amendments to the Transitional Provisions of the European Union MDR and IVDR

The proposed amendments aim to maintain patients’ access to a wide range of medical devices while ensuring the transition to the new framework. The ammendments proposal aims to extend the current transition period (Article 120 of the MDR), and it also deletes the ‘sell-off’ deadlines of both MDR and IVDR. The extension is staggered depending on the risk class of the device – until December 2027 for high-risk devices and December 2028 for medium and lower-risk devices.

Read More »
medical devices

EU MDR – Proposal for Extension of Transition Period

The transition to MDR has been slower than anticipated by the European Commission. Insufficient capacity of notified bodies and the low level of preparedness of manufacturers led to a proposal for extension of current MDR transition period with deadlines depending on the risk class of the devices.

Read More »
medical devices

MDCG 2022-18 – EU MDR Article 97

EU MDR Article 97 may be a temporary solution to avoid disruption of supply of Medical Devices on the EU Market. The MDCG 2022-18 presents a uniform approach for application of MDR Article 97 on non-compliant legacy devices under the conditions set by the competent authorities, while limiting the impact on the supply of safe and effective devices.

Read More »
parfum_fragrance_allergen_1
cosmetic products

EU to set Labelling Requirements for 56 additional Fragrance Allergens in Cosmetic Products

World Trade Organization (WTO) has been notified by the European Commission of a draft amendment to Regulation (EC) No 1223/2009 as regards labelling of fragrance allergens in Cosmetic Products. The proposed date of adoption of the new regulation is expected to be in the first half of 2023 and the propose date of entry in force 20 days from the publication in the Official Journal of the European Union.

Read More »
cosmetic products

New Amendments to the European Cosmetics Regulation – CMR Substances

The European Commission published the Commission Regulation (EU) 2022/1531, which amends Regulation (EC) No 1223/2009 in regards to the use in cosmetic products of certain substances classified as CMR. This amendment introduces new entries to Annex II and Annex III and revises an entry to Annex V to Regulation (EC) No 1223/2009.

Read More »